RAMSAY GENERALE DE SANTE SA Pharmaceuticals, Biotechnology & Life Sciences
$0.007
30 June 2023 at 3:17pm
High
$0.01Low
$0.01Trades
6Turnover
$9,683Volume
1,383,303
RAMSAY GENERALE DE SANTE SA
Pharmaceuticals, Biotechnology & Life Sciences
Grant of Options to CEO and Appendix 3G
RGS released this announcement to the ASX on 5 May 2021, 9:43. The announcement is not marked as price sensitive, and is 13 page(s) in length and 368.07kb in size.
You can view all announcements from RGS and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RGS | |
|---|---|
| Ceasing to be a substantial holder | 15 June 2023, 12:45 |
| Change in substantial holding | 1 May 2023, 8:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 11:28 |
| Grant of Options to CEO and Appendix 3G | 5 May 2021, 9:43 |
| Appendix 4C - Quarterly | 30 April 2021, 9:49 |
| Regeneus partners with Defence to treat combat casualties | 29 April 2021, 9:49 |
| Regeneus to be granted key Progenza patent in Europe | 16 March 2021, 8:56 |
If you were already registered, log in here.
If you were already registered, log in here.